Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses.
Nkgen Biotech stock last closed at $1.43, up 8.33% from the previous day, and has decreased 85.95% in one year. It has underperformed other stocks in the Biotechnology industry by 0.68 percentage points. Nkgen Biotech stock is currently +83.33% from its 52-week low of $0.78, and -88.9% from its 52-week high of $12.88.
As of May 3, 2024, there are 22.81M shares of NKGN outstanding. The market cap of NKGN is $32.61M. In the last 24 hours, 209,427 NKGN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy NKGN stock.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal info so you can invest in NKGN stock today.
Now that you have opened your account on the best stock app for beginners, you need to deposit funds:
Watch this video walkthrough for more details depositing funds into your investment account.
Once you have chosen the best place to buy Nkgen Biotech stock, it's important to analyze their stock prior to investing, so you actually understand the risk and upside.
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on NKGN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NKGN's true value.
You can do more valuation analysis on NKGN's stock here.
Last year, NKGN revenue was $0.00. During the past two year, NKGN's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 29.63%.
You can analyze NKGN's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at NKGN have bought more shares than they have sold.
Paul Y. Song, Chief Executive Officer of NKGN, was the latest NKGN insider to buy. They bought $250.04 worth of NKGN stock on Dec 7, 2023.
Research more about who owns NKGN shares here.
No, Nkgen Biotech doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main order types:
Click the Open Trade button and your broker will execute your order.
If you want additional help with buying stocks on eToro, watch the how to video below:
Now that you own some NKGN stock, you'll want to stay up-to-date on your shares.
Start a watchlist to get alerted to the latest events about your NKGN stock.
To reiterate, here are the 6 steps to buy Nkgen Biotech stock:
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Nkgen Biotech, add NKGN to your watchlist by clicking the button below.